排序方式: 共有1条查询结果,搜索用时 15 毫秒
1
1.
Molenaar JJ Koster J Zwijnenburg DA van Sluis P Valentijn LJ van der Ploeg I Hamdi M van Nes J Westerman BA van Arkel J Ebus ME Haneveld F Lakeman A Schild L Molenaar P Stroeken P van Noesel MM Ora I Santo EE Caron HN Westerhout EM Versteeg R 《Nature》2012,483(7391):589-593
Neuroblastoma is a childhood tumour of the peripheral sympathetic nervous system. The pathogenesis has for a long time been quite enigmatic, as only very few gene defects were identified in this often lethal tumour. Frequently detected gene alterations are limited to MYCN amplification (20%) and ALK activations (7%). Here we present a whole-genome sequence analysis of 87 neuroblastoma of all stages. Few recurrent amino-acid-changing mutations were found. In contrast, analysis of structural defects identified a local shredding of chromosomes, known as chromothripsis, in 18% of high-stage neuroblastoma. These tumours are associated with a poor outcome. Structural alterations recurrently affected ODZ3, PTPRD and CSMD1, which are involved in neuronal growth cone stabilization. In addition, ATRX, TIAM1 and a series of regulators of the Rac/Rho pathway were mutated, further implicating defects in neuritogenesis in neuroblastoma. Most tumours with defects in these genes were aggressive high-stage neuroblastomas, but did not carry MYCN amplifications. The genomic landscape of neuroblastoma therefore reveals two novel molecular defects, chromothripsis and neuritogenesis gene alterations, which frequently occur in high-risk tumours. 相似文献
1